Stockscreener 앱 받기
1.46
0.68%
-0.01
시간 외 거래:
1.46
Biovie Inc 주식(BIVI)의 최신 뉴스
BioVie (BIVI) Stock Analysis Report | Financials & Insights - Benzinga France
BioVie Inc. (BIVI) Stock Price, News, Quote & History - Yahoo! Finance Canada
BioVie Inc. (BIVIW) Stock Price, News, Quote & History - Yahoo! Finance Canada
BioVie Inc. (BIVI) Latest Stock News & HeadlinesYahoo Finance - Yahoo! Finance Canada
New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global - guardonline.com
Join BioVie's Exclusive Live Investor Webinar: Inside the ADDRESS-LC Phase 2 Results - ACCESS Newswire
BIVI 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investors with Substantial Losses to Contact its Attorneys Before Mar. 19th Deadline in Securities Fraud Class Action Over Failed Phase 3 Clinical Trial - TMX Newsfile
BioVie Deadline Alert - TMX Newsfile
New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global - Eagle-Tribune
Alliance Entertainment and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - Yahoo Finance
BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim in Long CovidSlideshow (NASDAQ:BIVI) 2026-09-17 - Seeking Alpha
BIVI Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus as Shares Slip 2.29%Product Revenue Analysis - careplusvn.com
Biovie Inc (BIVI) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
What's Going On With BioVie Stock on Tuesday?BioVie (NASDAQ:BIVI) - Benzinga
BioVie Shares Fall 9.7% After Long COVID Trial Misses Statistical Significance in Full Population - Yahoo Finance
Why is BioVie stock sliding today? By Investing.com - Investing.com Canada
BioVie reports phase 2 long COVID trial results By Investing.com - Investing.com Australia
BioVie Plans Phase III Study After Long COVID Drug Shows Subgroup Signals - insights.citeline.com
BioVie Reports Topline Phase 2 ADDRESS-LC Results Showing Bezisterim Benefits in Long COVID Subgroups with High Symptom Burden - Quiver Quantitative
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - Yahoo Finance
BioVie Phase 2 trial shows bezisterim eases fatigue, cognitive symptoms in severe Long COVID cases - Proactive financial news
Biovie Inc (BIVI) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
BioVie to Host Conference Call to Discuss Topline Data from - GlobeNewswire
BioVie Signs ATM Sales Agreement to Offer Up to $6.46 Million in Stock - Minichart
Form 8K Biovie Inc For: 14 September By Investing.com - Investing.com Canada
BioVie Inc Files for Atm Offering of up to Ab - Moomoo
BIVI 8-K FilingsBioVie, Inc. SEC 8-K - Stock Titan
How much new stock can BioVie (NASDAQ: BIVI) now sell into the market? - Stock Titan
Biovie seeks FDA meeting to plan Phase 3 trial for Parkinson’s drug candidate - Parkinson's News Today
Jane Street Group Expands BioVie Inc (BIVI) Stake by Over 1,100% - GuruFocus
Market movers: Novartis, Qualcomm, EchoStar, BioVie... - proactiveinvestors.com
BioVie advances bezisterim Phase 3 Parkinson’s trial - grafa.com
BioVie advances Parkinson’s Phase 3 trial plans after positive Phase 2 results and FDA engagement. - Pluang
BioVie advances Parkinson’s Phase 3 development program with FDA engagement - Yahoo Finance
BioVie Announces Update to Parkinson’s Phase 3 Development Program - markets.businessinsider.com
BioVie seeks FDA feedback on a proposed Parkinson’s trial of about 175 patients. - Stock Titan
BIVI Form 4 FilingsBioVie, Inc. SEC Form 4 - Stock Titan
Biovie Stock Price Forecast. Should You Buy BIVI? - StockInvest.us
Jane Street reports over 5% stake in BioVie (BIVI) - stocktitan.net
Small cap wrap: Alvopetro, Royal Road Minerals, Nextech3D.ai, TNR Gold... - Proactive financial news
Market movers: PG&E, Aon, Eli Lilly, BioVie... - Proactive financial news
BioVie completes final patient visit in Phase 2 Long COVID trial, topline results due by September 2026 - Pluang
BioVie (BIVI) Completes Final Visit in ADDRESS-LC Phase 2 Trial for Long COVID Neurological Symptoms - GuruFocus
BioVie Announces Completion of Treatment Phase of - GlobeNewswire
Dow falls as US strikes Iran, rate-hike bets jump - proactiveinvestors.co.uk
Biovie Inc (BIVI) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioVie completes final patient visit in Phase 2 Long COVID trial - Proactive financial news
Price to earnings forward of BioVie Inc. – BOATS:BIVIW - TradingView
0.05%
0.82%
자본화:
|
볼륨(24시간):